Skip to content
Screener

Hinge Health HNGE Financing Cash Flow

Financing Cash Flow at other companies

Teladoc Health logo
Teladoc HealthTDOC
-$2.45M-418%
Globus Medical logo
Globus MedicalGMED
-$134.5M-439%
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
$2.45M-7.2%
National Research Corporation logo
National Research CorporationNRC
$718K-89.6%
LifeMD, Inc. logo
LifeMD, Inc.LFMD
-$696.04K+14.3%
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
-$271.1M-266%

Other financials

Income statement

See full
Revenue$212.8M+53.0%
Gross profit$183.9M+88.2%
Operating income$40.4M+107%
Net income$43.7M+108%
EPS (diluted)$0.52+104%

Balance sheet

See full
Cash & equivalents$287.7M+20.4%
Total debt$5.9M-40.9%
Total equity$344.3M+98.1%
Total assets$827.4M+19.3%

Cash flow

See full
Operating cash flow$101.4M+401%
CapEx$123.0K-37.6%
Free cash flow$101.3M+406%

Valuation

See full
Market cap$6.2B+31.2%
Enterprise value$5.91B+31.6%
P/E80.5×
P/S8.6×-1.2×

Profitability

See full
Gross margin84.5%+6.8pp
Operating margin9.2%
Net margin10.7%
FCF margin40.3%+21.3pp

Returns & leverage

See full
Return on equity29.7%
Debt / equity0.0×
Current ratio1.3×-0.6×

Where this comes from

Reported directly by Hinge Health in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.

The source filing: Hinge Health’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 4:14 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-054327
Line itemSix Months Ended June 30, 2026Six Months Ended June 30, 2025
Payment on Repurchase Agreement with Coatue(50,000)
Proceeds from repayment of non-recourse loans to employees4,934
Payments for deferred offering costs(10,061)
Net cash used in financing activities(143,326)(71,454)
Net increase (decrease) in cash, cash equivalents, and restricted cash77,869(63,614)
Cash, cash equivalents, and restricted cash, beginning of period209,796302,586
Cash, cash equivalents, and restricted cash, end of period$287,665$238,972
Reconciliation of cash, cash equivalents, and restricted cash to the unaudited condensed consolidated balance sheets:

Item 1. Financial Statements (Unaudited)

FAQ

What is Hinge Health's financing cash flow?
Hinge Health (HNGE) reported financing cash flow of -$30.48M in Q2 2026.
How has Hinge Health's financing cash flow changed year-over-year?
Hinge Health's financing cash flow increased by 59.7% year-over-year, from -$75.56M to -$30.48M.
What does financing cash flow mean?
Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.

Ask your AI about Hinge Health's financing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude